Get started

Funds · ORMP

Who owns ORMP?

Institutional ownership of Oramed Pharmaceuticals Inc. from Form 13F, Q2 2026

84 institutional managers reported holding Oramed Pharmaceuticals Inc. (ORMP) in Form 13F filings for Q2 2026, with 16,773,404 shares worth $80.7M. The largest reported holder was Mercer Global Advisors Inc. Managers that filed both quarters added a net 3,533,661 shares (+26.7%). 29 opened new positions and 8 sold out.

Funds holding
84
Value held
$80.7M
New / sold out
29 / 8
Net shares, same filers
+26.7%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of ORMP

FundValueShare of 13F holdingsSharesMove
Mercer Global Advisors Inc$18.3M22.7%3,810,540Added
Aquamarine Financial (Cayman) Ltd$12.1M15.0%2,512,175Added
Gem Investment Advisors, LLC$9.6M11.9%1,998,802Added
BlackRock, Inc.$7.7M9.6%1,608,111Added
Murchinson Ltd.$6.2M7.7%1,290,294Trimmed
BML Capital Management, LLC$4.2M5.2%866,269Trimmed
Boothbay Fund Management, LLC$2.8M3.4%578,638Trimmed
Geode Capital Management, LLC$2.4M3.0%500,690Added
Goldman Sachs Group Inc$1.2M1.5%253,293New
State Street Corp$1.2M1.4%242,100New
Rathbones Group PLC$1.1M1.4%233,018Unchanged
Vanguard Portfolio Management LLC$1.1M1.4%229,882New
Dimensional Fund Advisors LP$974K1.2%202,609Added
Northern Trust Corp$889K1.1%184,920New
Renaissance Technologies LLC$884K1.1%183,800Added
Wells Fargo & Company$798K1.0%166,000Added
Bank of America Corp$725K0.9%150,694Added
STRS Ohio$644K0.8%133,800New
Jane Street Group, LLC$545K0.7%113,349Added
O'Shaughnessy Asset Management, LLC$495K0.6%102,962Trimmed
Marshall Wace, LLP$490K0.6%101,953Trimmed
HRT Financial LP$469K0.6%97,582Added
Hillsdale Investment Management Inc.$430K0.5%89,300Trimmed
Ritholtz Wealth Management$406K0.5%84,347Trimmed
Charles Schwab Investment Management Inc$402K0.5%83,634New

Share of 13F holdings is each fund's shares as a share of the 16,773,404 ORMP shares all 13F filers reported, not of shares outstanding.

Biggest buyers in Q2 2026

  1. Mercer Global Advisors Inc Added+$9.1M
  2. BlackRock, Inc. Added+$7.3M
  3. Geode Capital Management, LLC Added+$2.3M
  4. Aquamarine Financial (Cayman) Ltd Added+$1.9M
  5. Gem Investment Advisors, LLC Added+$1.7M
  6. Goldman Sachs Group Inc New+$1.2M
  7. State Street Corp New+$1.2M
  8. Vanguard Portfolio Management LLC New+$1.1M
  9. Northern Trust Corp New+$889K
  10. STRS Ohio New+$644K

Biggest sellers in Q2 2026

  1. BML Capital Management, LLC Trimmed-$11.1M
  2. Marshall Wace, LLP Trimmed-$758K
  3. Susquehanna International Group, LLP Trimmed-$548K
  4. Ritholtz Wealth Management Trimmed-$342K
  5. Citadel Advisors LLC Trimmed-$274K
  6. Hudson Bay Capital Management LP Trimmed-$199K
  7. Murchinson Ltd. Trimmed-$120K
  8. Connor, Clark & Lunn Investment Management Ltd. Trimmed-$120K
  9. Boothbay Fund Management, LLC Trimmed-$106K
  10. Point72 Asset Management, L.P. Sold out-$89K

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $31.4M and sold $14.2M; 21 added and 19 trimmed.

Questions about ORMP ownership

Who owns ORMP stock?
84 institutional investment managers reported ORMP positions in their Form 13F filings for Q2 2026, holding 16,773,404 shares worth $80.7M in total. Mercer Global Advisors Inc reported the largest position.
Are funds buying or selling ORMP?
In Q2 2026, 29 managers opened new ORMP positions, 21 added, 19 trimmed and 8 sold out. Managers that filed in both quarters added a net 3,533,661 shares.
How current is this ORMP institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to ORMP by CUSIP. Options are left out. ORMP news and filings · ORMP insider trades · Top funds